Essex Investment Management CO LLC Reata Pharmaceuticals Inc Transaction History

Essex Investment Management CO LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 12, 2021	SELL	$94.25 - $132.81 $2,733 - $3,851	-29 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$102.03 - $184.62 $1 Million - $1.81 Million	-9,805 Reduced 99.71%	29 $4,000
Q3 2020 Nov 12, 2020	BUY	$93.53 - $163.34 $919,774 - $1.61 Million	9,834 New	9,834 $958,000
Q2 2020 Aug 04, 2020	SELL	$126.3 - $176.56 $1.26 Million - $1.77 Million	-10,000 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$74.57 - $217.92 $745,699 - $2.18 Million	10,000 New	10,000 $2.04 Million
Q2 2018 Jul 17, 2018	SELL	$19.94 - $40.96 $409,906 - $842,014	-20,557 Closed	0 $0
Q1 2018 Apr 26, 2018	BUY	$20.0 - $30.19 $411,140 - $620,615	20,557 New	20,557 $422,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Essex Investment Management CO LLC, based on Form 13F filings with the SEC.

Stay updated on Essex Investment Management CO LLC with notifications on news.